Inactive Instrument

Ambrx Inc Share Price

Stocks

US02337M1018

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

Press Releases: Ambrx Inc

17/08/16	Ambrx : Innovative Antibody Drug Conjugate (ADC) US IND Active	PU
04/08/16	Ambrx : closes $45M round of financing	PU
16/11/15	Ambrx : Announces New Chief Medical Officer	PU
19/06/15	Ambrx : Names Dr. Tiecheng Qiao as CEO, Dr. Feng Tian as CSO	PU
19/06/15	Ambrx : Chinese Consortium Enters into Agreement to Acquire Ambrx	PU

More press releases

Managers and Directors: Ambrx Inc

Manager	Title	Age	Since
Margaret Yu CEO	Chief Executive Officer	-	-
Sonja Nelson DFI	Director of Finance/CFO	53	31/05/2021
Sandra Aung CTO	Chief Tech/Sci/R&D Officer	-	31/01/2023

Director	Title	Age	Since
Paul Maier BRD	Director/Board Member	78	31/01/2022
Janet Loesberg BRD	Director/Board Member	63	31/05/2022

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	WUXI APPTEC CO., LTD.	-1.38%	+0.20%	+46.42%	+96.33%	69.18B
	ARGENX SE	-1.04%	-0.81%	+34.61%	+75.16%	62B
	INSMED INCORPORATED	-4.29%	-3.98%	-16.22%	+350.66%	26.19B
	WUXI BIOLOGICS (CAYMAN) INC.	+2.19%	+3.09%	+29.90%	+15.48%	25.75B
	BIONTECH SE	-2.20%	-2.00%	-1.22%	-14.48%	24.29B
	GENMAB A/S	+1.61%	-0.69%	+20.85%	-19.42%	19.84B
	PHARMAESSENTIA CORPORATION	+1.26%	-14.23%	+170.04%	+298.75%	15.65B
	SUMMIT THERAPEUTICS INC.	-5.54%	+0.69%	-8.13%	+830.48%	13.88B
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.17%	-3.99%	-9.63%	+456.39%	14.09B
	Average	-1.05%	-2.20%	+29.62%	+232.15%	30.1B
	Weighted average by Cap.	-1.08%	-1.32%	+31.38%	+158.02%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!